Pregnancy Clinical Trial
Official title:
Evaluating How a Mobile App Can Improve Prenatal Care: A Randomized Controlled Trial
Throughout the Military Health System, pregnant mothers are issued a spiral-bound guide that
provides week by week information about pregnancy, preventive health messages, appointment
information, and space to record their experiences throughout their pregnancy. When used
accordingly, the evidence-based guide is an effective tool for motivating patients to
participate in their own healthcare and achieve care goals. However, the spiral-bound paper
modality results in patients forgetting the book for appointments or losing it. By testing a
mobile application (app) from the current publication, the MHS leverages the efforts which
created the guide while increasing patient and provider use.
The multisite testing (randomized controlled trial) of a mobile application developed from
the current spiral-bound "Pregnancy and Childbirth: A Goal Oriented Guide to Prenatal Care"
created by the VA and DoD provides an innovative, cost-effective opportunity to improve
provider-patient communication and patient care.
The study was conducted in the women's health and family medicine departments of one
community hospital and two medical centers across three states (Georgia, Nevada, and
Virginia). In this hospital system, women are distributed a spiral notebook at their
obstetric care intake appointment, which generally is scheduled for 8-10 weeks gestation. The
spiral notebook is designed for two purposes: 1) patient education of what happens throughout
pregnancy, and 2) patient record keeping of the patient's own pregnancy experience, including
space for recording weight, blood pressure, and journaling about what they experience between
prenatal appointments. The mobile app used in this study was designed for the same two
purposes and contained identical content, though through a mobile design interface (available
on both Android and iOS platforms). After the pilot study, patient feedback on the mobile app
was used to create a beta version. Notable differences were a feature for users to change
font size, a search function, and weekly reminders. No substantive content changed. This
randomized controlled study had one intervention (mobile application) and one control
(standard of care - spiral notebook) group. The study was approved by the first author's
Institutional Review Board.
At each medical center, the obstetrics intake nurse serially screened new obstetrics patients
for inclusion criteria from May to November 2015. If patients met inclusion criteria, the
nurse invited the patient to talk to a research assistant about the study. Exclusion criteria
included conditions that would elevate the patient's care to complicated obstetrics care
(e.g., cardiovascular disease, diabetes mellitus, renal disorder, etc.). This was intended to
capture a low-risk obstetrics patient population that would follow a standard 4-week pathway
of care, in which patients attend a prenatal appointment once every four weeks during
pregnancy.
The study used pre-assigned block randomization (each block n = 40) to balance the conditions
throughout recruitment. Following consent and baseline measures, participants were randomized
to the two conditions. Providers were blinded to patient participation in the study.
Surveys were completed at four prenatal appointments, 10-12 weeks, 28 weeks, 32 weeks, and 36
weeks gestation. All data collection was conducted with paper-and-pencil surveys in the
clinic, immediately before and following each clinical appointment. At each appointment,
patient weight and blood pressure were also recorded from the patient's electronic medical
record.
At baseline, self-reported measures included demographics, health literacy, and patient
activation. Health literacy was assessed using the self-reported Functional, Communicative,
Critical Health Literacy Scale (Ishikawa, Takeuchi, & Yano, 2008) Patient activation was
assessed with the validated, licensed patient activation measure (PAM) (Greene & Hibbard,
2012; Greene, Hibbard, Sacks, & Overton, 2013; Hibbard, Mahoney, Stockard, & Tusler, 2005;
Hibbard et al., 2004), which uses 13 Likert-type items to create a continuous patient
activation measure on a scale of 0 (not activated) to 100 (most activated). PAM was also
replicated at time 4 (32 week appointment). As a surrogate measure, patient activation was
also assessed at a behavioral level by asking patients at 36 weeks how many mobile apps they
had used throughout their pregnancy.
Use was assessed with three measures. Before each appointment, patients completed two items
regarding use of the education and engagement tool. First they indicated if they had brought
the mobile app/notebook to the appointment with them (yes/no). Then, they reported how
frequently they had used the tool over the past month 1) to look for information and 2) to
record information (never = 0, once = 1, weekly = 4, or daily = 28).
Following each appointment, patients completed five subscales of the validated Prenatal
Interpersonal Processes of Care (PIPC) scale (Wong et al., 2004), including
elicitation/responsiveness to the patient, explanations of care, empowerment,
patient-centered decision making, and emotional support. Responses to each item were
transformed onto a 0 (negative perception) to 100 (positive perception) scale, and items are
averaged to create subscales. Then subscales are averaged to calculate the overall PIPC
scale.
At delivery, outcomes were recorded from the health record: gestational age, birth weight,
and mode of delivery (vaginal or Caesarean section).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |